Fig. 3From: The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicityFrequency of common (MAF ≥ 1%) and rare (MAF < 1%, including novel) variants according to gene in patients with and without toxicityBack to article page